Transgenic mouse models of lipoprotein metabolism and atherosclerosis
about
Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levelsIn utero arsenic exposure induces early onset of atherosclerosis in ApoE-/- miceImpaired electroretinogram (ERG) response in apolipoprotein E-deficient miceMouse models of arteriosclerosis: from arterial injuries to vascular grafts.Cholesterol in the retina: the best is yet to come.The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption.The fat-fed apolipoprotein E knockout mouse brachiocephalic artery in the study of atherosclerotic plaque ruptureStage-specific remodeling of atherosclerotic lesions upon cholesterol lowering in LDL receptor knockout miceEndothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging.Mouse model of venous bypass graft arteriosclerosis.Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectorsHuman ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic miceCholesterol in mouse retina originates primarily from in situ de novo biosynthesis.Genes and physiology: molecular physiology in genetically engineered animals.Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studiesThe maltose transport system of Escherichia coli displays positive cooperativity in ATP hydrolysis.A pivotal role for TGF-beta in atherogenesis?Accelerated atheromatous lesions in mouse hearts transplanted to apolipoprotein-E-deficient recipients.Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice.CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans.Reduced progression of atherosclerosis in apolipoprotein E-deficient mice treated with lacidipine is associated with a decreased susceptibility of low-density lipoprotein to oxidation.A novel endothelial cell-based gene therapy platform for the in vivo delivery of apolipoprotein E.Effects of social isolation and environmental enrichment on atherosclerosis in ApoE-/- mice.Brains of aged apolipoprotein E-deficient mice have increased levels of F2-isoprostanes, in vivo markers of lipid peroxidation.Comprehensive MRI for the detection of subtle alterations in diastolic cardiac function in apoE/LDLR(-/-) mice with advanced atherosclerosis.Historical Perspective: Phosphatidylserine and Phosphatidylethanolamine from the 1800s to the Present.Transcriptional profile reveals altered hepatic lipid and cholesterol metabolism in hyposulfatemic NaS1 null mice
P2860
Q24562095-5E405855-9E69-4856-B479-AF281CDDC299Q28396600-4E7F5A5D-1F96-48E3-95A6-734990E4D829Q28588554-7C4BC97C-7EC8-4869-B234-E841A5D3FC58Q30481132-642D6EFB-6054-451C-A047-A372FDE97591Q33758267-CF8DF966-6A88-43FE-9D6F-81616D2BBA11Q33837099-58F30CBA-359F-476A-BC7A-FA21AC84C380Q34181941-F20F0661-E403-4634-9234-F4C8689A3AEAQ34289373-13A866F0-F3FE-43F1-9BD0-3F8B638090B4Q35167972-E206B19D-C2ED-402B-B01E-C769BB375629Q35636955-F99F59B1-0414-4A9E-9201-CCCBD5F2DD5CQ35753478-BDEDFDDC-1055-4F06-B03D-DE5068F5A36CQ35763533-32DE0A7B-6D8F-459D-A45F-23B29086C7F1Q35824669-4AB8C169-C0F6-46F6-A627-4DA07156C7D2Q36503832-19D0CD86-FDE2-41BA-88E4-048ED5E5FFE9Q37351939-FDF6CE6E-BE33-42B9-BBBB-AE8518BEF1EFQ37355372-00DD7050-EFCB-4F20-8162-88A39AB69DA4Q38175374-0F8E830F-3FF6-4723-BB5C-7C6FEBB761A2Q38361204-49A43FD9-6107-4EA3-9852-5EAB0C10BD7FQ40926437-0EF0A2C5-2B73-4B44-B7BC-0861BDA55414Q42233317-E04CBBB9-11BB-4E1C-B014-BBA203EB9FB8Q43794376-2B8D19F8-999F-4B6D-82B8-FEC7C6B23742Q44499486-42DB9383-E936-45AB-AD18-25431BFE7191Q44904233-0574D8AC-8DE2-404F-AC93-FF9D19F3D79DQ45861575-1E59BE76-BC9F-477B-AD5F-385389FE6615Q46495769-BB340352-A61C-4355-A5AD-4A8E8176DE96Q48148963-2BD7DF09-100D-4499-82D9-C4BCBF9087CCQ50202265-C31433DB-C506-4C95-A69A-0DA48003121BQ52691331-857AF0EC-6A8D-4B47-8893-B7BE04B94D3DQ57423362-CC4C5A34-E2A8-43B4-AEA6-B4AE15CA3D82
P2860
Transgenic mouse models of lipoprotein metabolism and atherosclerosis
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Transgenic mouse models of lipoprotein metabolism and atherosclerosis
@ast
Transgenic mouse models of lipoprotein metabolism and atherosclerosis
@en
type
label
Transgenic mouse models of lipoprotein metabolism and atherosclerosis
@ast
Transgenic mouse models of lipoprotein metabolism and atherosclerosis
@en
prefLabel
Transgenic mouse models of lipoprotein metabolism and atherosclerosis
@ast
Transgenic mouse models of lipoprotein metabolism and atherosclerosis
@en
P2860
P356
P1476
Transgenic mouse models of lipoprotein metabolism and atherosclerosis
@en
P2093
Breslow JL
P2860
P304
P356
10.1073/PNAS.90.18.8314
P407
P577
1993-09-01T00:00:00Z